Perubahan Disintegran Pada Formula Tablet untuk Efisiensi Biaya Produksi
Abstrak
Formula alternatif diperlukan dalam proses pengembangan formula, formula ini dibuat untuk menurunkan biaya produksi tanpa menurunkan kualitas produk. Pada formula tablet yang akan dikembangkan dilakukan penggantian eksipien yaitu disintegran karena konsentrasi disintegran yang digunakan lebih tinggi jika dibandingkan eksipien lainnya dan memiliki harga yang cukup mahal. Disintegran pada formula sebelumnya adalah croscarmellose sodium dengan 5% yang merupakan jenis superdisintegran. Dalam mengganti disintegran diperlukan studi literatur untuk membandingkan kemampuan disintegran tersebut, selain itu juga harus mempertimbangkan harga dari bahan baku. Hasil studi literatur dan perbandingan harga, menunjukkan bahwa sodium starch glikolat dengan konsentrasi 4% merupakan disintegran yang paling tepat untuk menggantikan croscarmellose sodium.
Kata kunci: Formula alternatif, disintegran, efisiensi biaya.
Teks Lengkap:
PDFReferensi
Alderborn, G. 2002. Tablets and Compaction, In: Pharmaceutics : The Science of Dosage Form Design, Second Ed., 413, 423-424, 431, 437, United Kingdom: Churchill Livingstone.
Belet, M. H and Derle, D. V. 2008. Analysis of patents pertaining to superdisintegrants used in tablet manufacturing. Journal of intellectual Property Rights, 13: 601-604.
Saputro, B. 2017. Manajemen Penilitian Pengembangan (Research and Development) Edisi I. Yogyakarta: Aswaja Pressindo
Chetan, G.P and Shivprasad, H.M. 2012. Comparative Success of Natural Superdisintegrant in Fast Disintegrating Tablets. Asian J Biomed Pharm Sci. Vol 2 : 69- 72.
Erum S., Fouzia H., Syed M.F.H., and Sabahat J., 2011. Formulation of Aspirin Tablets Using Fewer Excipients by Direct Compression. Pakistan Journal of Pharmacology Vol.28, No.1, 31-37
Konapure, A. S., Chaudhari P. S., Oswal R. J., Kshirsagar S.S, Antre RV and Chorage TV. 2011. Mouth dissolving tablets-an innovative technology. International Journal of Applied Biology and Pharmaceutical Technology, 2(1): 496-503.
Moghal, M. M., Mazumder, S., Lira, D., & Rouf, A. S. 2016. Fabrication and in vitro Evaluation of Allopurinol Fast Dissolving Tablets Using Croscarmellose Sodium, Sodium Starch Glycolate and Crospovidone as Superdisintegrants. Dhaka University Journal of Pharmaceutical Sciences, 15(1), 73-81.
Pahwa, R and Gupta, Nisha. 2011. Superdisintegrants in the Development of Orally Disintegrating Tablets: A Review. International Journal of Pharmaceutical Sciences and Research. Vol. 2(11): 2767-80.
Priyanka, S and Sethi, V. 2013. A Review Article on : Superdisintegrants. International Journal of Drug Research and Technology. Vol 3(4) : 76-87.
Rajesh, Y.V., Balasubramaniam, J., Bindu, K., Sridevi, R., Swetha, M., and Rao, V.U. 2010. Impact of Superdisintegrants on Efavirenz Release from Tablet Formulations. Acta Pharm. Vol 60 (2) : 185-95.
Rowe, R.C., Sheskey, P.J. and Owen, S.C. 2009. Handbook of Pharmaceutical Exipients. 6th ed. London and American: Pharmaceutical Press.
Sanket, K dan Garg, S.K.R. 2014. Fast Dissolving Tablets (FDTs): Current Status, New Opportunities, Recent Advances in Manufaturing Technologies and Future Prospects. International Journal of Pharmacy and Pharmaceutical Sciences Vol 6, Hal 7
Shailendra, B. dan Priti, T. 2011. Taste Masking of Ondansentron Hydrochloride and Formulation of Fast Dissolving Tablets. J. Chem. Pharm. Res. 3(4): 472- 484.
Sulaiman, T.N.S. 2007. Teknologi dan Formulasi Sediaan Tablet. Yogyakarta: Pustaka Laboratorium Teknologi Farmasi Fakultas Farmasi UGM.
Syamsuni, A. 2014. Ilmu Resep. Jakarta: EGC. 147; 172-173
Thakare V, Jadhao U, Chaudhari K, dan Mahajan P. 2013. Development of metoclopramide hydrochloride orodispersible tablets using taste masking agent. Journal of Advanced Pharmacy Education & Research, 3(4):480–486.
Thulluru, A., Kumar, K.M., Priya, E. Chandana., Mounika, R., dan Munichandra, K. Formulation and evaluation of Tadalafil oral disintegrating tablets with enhanced dissolution rate by complexation. International Journal of Research and Development in Pharmacy & Life Science, 6(3): 2631-2640.
DOI: https://doi.org/10.24198/farmaka.v19i4.32278
DOI (PDF): https://doi.org/10.24198/farmaka.v19i4.32278.g16837
Refbacks
- Saat ini tidak ada refbacks.
Sitasi manajer:
Jurnal ini diindeks dalam:
Farmaka by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Copyright © 2013 Jurnal Farmaka - All Right Reserved